Martin Auster - 04 Feb 2022 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role: Chief Financial Officer
Signature: /s/ Christopher Krueger, as Attorney-in-Fact
Issuer symbol: VTYX
Transactions as of: 04 Feb 2022
Net transactions value: $0
Form type: 4
Filing time: 04 Feb 2022, 17:42:03 UTC
Previous filing: 20 Oct 2021
Next filing: 06 Dec 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VTYX	Stock Option (right to buy)	Award	$0	+145,000		$0.000000	145,000	04 Feb 2022	Common Stock	145,000	$12.21	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 3, 2022.

Content

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 3, 2022.